Validation of tissue microarray technology using cervical adenocarcinoma and its precursors as a model system

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 1225-1233

  Tawfik El Mansi, M ^a,b   Williams, A R W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

CEA; Cervical adenocarcinoma; CK20; CK7; Immunohistochemistry; Tissue microarray (TMA) technology

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; CARCINOEMBRYONIC ANTIGEN; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; MICROARRAY ANALYSIS; MODELS, BIOLOGICAL; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 33745068651     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00570.x     Document Type: Article

References (25)

1. Andersson S Rylander E Larsson B Strand A Silfversvard C Wilander E. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 2001 37 : 246 50.
2. Bonds L Baker P Gup C Shroyer KR. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix. Arch Pathol Lab Med 2002 126 : 1164 8.
3. Mathers ME Johnson SJ Wadehra V. How predictive is a cervical smear suggesting glandular neoplasia? Cytopathology 2002 13 : 83 91.
4. Cordon-Cardo C. Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 1997 147 : 545 60.
5. Hoos A Urist MJ Stojadinovic A et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumours. Am J Pathol 2001 158 : 1245 51.
6. Fernebro E Dictor M Bendahl PO Ferno M Nilbert M. Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. Arch Pathol Lab Med 2002 126 : 702 5.
7. Wright JJ. The development of the frozen section technique, the evolution of surgical biopsy, and the origins of surgical pathology. Bull Hist Med 1985 59 : 295 326.
8. Kononen J Bubendorf L Kallioniemi A et al. Tissue microarrays for high-throughput molecular profiling of tumour specimens. Nat Med 1998 4 : 844 7.
9. Bubendorf L Kononen J Koivisto P et al. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res 1999 59 : 803 6.
10. Moch H Schraml P Bubendorf L et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 1999 154 : 981 6.
11. Schraml P Kononen J Bubendorf L et al. Tissue microarrays for gene amplification surveys in many different tumour types. Clin Cancer Res 1999 5 : 1966 75.
12. Mucci NR Akdas G Manely S Rubin MA. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol 2000 31 : 406 14.
13. Perrone EE Theoharis C Mucci NR et al. Tissue microarray assessment of prostate cancer tumour proliferation in African-American and white men. J Natl Cancer Inst 2000 92 : 937 9.
14. Mills SE Fechner RE Frierson HF et al. Guardians of the wax and the patient. Am J Clin Pathol 1995 104 : 365 7.
15. Camp RL Charette LA Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000 80 : 1943 9.
16. Engellau J Akerman M Anderson H et al. Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma. Appl Immunohistochem Mol Morphol 2001 9 : 358 63.
17. Hoos A Lewis JJ Antonescu CR et al. Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumours. Cancer Res 2001 61 : 3171 5.
18. Kallioniemi OP Wagner U Kononen J Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001 10 : 657 62.
19. Shibata D Martin WJ Arnheim N. Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology. Cancer Res 1988 48 : 4564 6.
20. Ibrahim SO Johannessen AC Vasstrand EN Lillehaug J Nilsen R. Immunohistochemical detection of p53 in archival formalin-fixed tissues of lip and intraoral squamous cell carcinomas from Norway. APMIS 1997 105 : 757 64.
21. Hoos A Cordon-Cardo C. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest 2001 81 : 1331 8.
22. Alkushi A Irving J Hsu F et al. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Arch 2003 442 : 271 7.
23. Chu P Weiss L. Keratin expression in human tissues and neoplasms. Histopathology 2002 40 : 403.
24. Cina SJ Richardson MS Austin RM Kurman RJ. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 1997 10 : 176 80.
25. Bubendorf L Nocito A Moch H Sauter G. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001 195 : 72 9.